Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
about
Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.N-Aroyl indole thiobarbituric acids as inhibitors of DNA repair and replication stress response polymerases.Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1ATM signalling and cancer.Mastl kinase, a promising therapeutic target, promotes cancer recurrence.Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cisCell fate determination in cisplatin resistance and chemosensitizationContribution of LATS1 and LATS2 promoter methylation in OSCC development.AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway.Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.The molecular mechanisms of chemoresistance in cancers.HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma.Molecular mechanisms of drug resistance in ovarian cancer.MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.Identification of new inhibitors against human Great wall kinase using in silico approaches.53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells.
P2860
Q27330365-81B145DC-7087-423C-A087-F9AC508E2365Q31117517-34E81A5C-30EB-4CFF-8276-DE11A54F18C3Q33638575-1EED2AAF-AFCE-4A83-B989-28DD3A3F4A4FQ34357377-A09D487E-1A97-4D34-BF1E-193A1391CB72Q34957406-8DCAD99F-E932-4D54-BCE5-1FDD81B2AA25Q35084936-E32BADAA-731F-403F-AD9B-60EDF8FEEBD7Q37269025-E321DC58-9631-4B1E-B385-B0CECD9389D3Q37716706-2DFD6F89-7A86-40E4-8E95-128776B43D25Q38150151-E654EE20-6E57-4682-972D-D91BB2114A64Q39447639-3CDD6AC0-A31D-44CA-8D00-CA26F88B86D8Q41637438-FF9855C2-DCBC-4E04-8205-260A37B06530Q41709101-EF1361FE-6EB9-4AFE-8134-6FBD24C56AC3Q47551132-4EC7F5E2-7A0F-481B-9401-3268D3815F0BQ48274587-B00ED9BD-E2AE-495C-AF40-C1E646FC41D0Q52605242-1FC8459D-E6EB-46C2-B017-C0AE5FBE18D4Q52725387-1F45018B-E147-4D0F-9604-FB1EB83EBF0AQ55280419-402B2636-BDF6-4208-A798-A29C00923C06
P2860
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@ast
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@en
type
label
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@ast
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@en
prefLabel
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@ast
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@en
P2093
P2860
P1476
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer
@en
P2093
Adam J Mosel
Aimin Peng
P2860
P304
P356
10.1158/1535-7163.MCT-12-0448
P577
2012-09-12T00:00:00Z